Tectonic Therapeutic, Inc. (TECX) financial statements and ratios from SEC XBRL: revenue $11.30M (TTM), net margin -656.4%, revenue growth 165.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $11.30M |
| Net Margin | -656.4% |
| Revenue Growth (YoY) | 165.1% |
| EPS Growth (YoY) | -40.7% |
| FCF Growth (YoY) | 1.8% |
| Price / Book | 2.94 |
| Price / Sales | 62.15 |
| FCF Yield | -15.5% |
| Altman Z-Score | 40.64 (safe) |
| Sector P/E (Healthcare) | 21.6 |
TECX overview · TECX earnings · TECX KPIs · TECX investor relations · TECX ownership · TECX peers · TECX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.